Wouldn’t mind being there, because Rennie
will likely use this forum to announce a go
ahead from FDA to proceed with 2x2 dosing
for P3, without any strings attached and permission
by TGA to proceed with DMOAD submission.
Also, an immediate $100M upfront payment
from J&J with 25% royalty from marketing
Zilosul, post regulatory approval. I would have
preferred CSL to keep it Aussie, but beggars
can’t be choosers.
We will also hear about the many Pharma
companies (big and small) who were vying
for a piece of the action.
Yeh, right.
research reports and media, page-4174
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $36.40K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40816 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 44646 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |